d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] Pazopanib in Advanced GISTs Refractory to Imatinib and Sunitinib - A Non-comparative Phase II Multicenter Study by the Scandinavian Sarcoma Group [Country] NO [Cancer type] 
Sarcoma
Nordic NECT - Inclusion completed
Cancer type